Hypothalamic galanin is up-regulated during hyperphagia and increased body weight gain induced by disruption of signaling in the ventromedial nucleus

Peptides

Volumn 21, Issue 4, 2000, Pages 519-526

  Dube, Michael G ^a   Kalra, Satya P ^a   Kalra, Pushpa S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Amygdala; Colchicine; Dorsomedial nucleus; Insulin; Lateral hypothalamic area; Leptin; Paraventricular nucleus; Perifornical hypothalamus

Indexed keywords

COLCHICINE; GALANIN; INSULIN; LEPTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BLOOD LEVEL; BRAIN REGION; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; INSULIN BLOOD LEVEL; LATERAL HYPOTHALAMUS; MALE; MEDIAN EMINENCE; MICROINJECTION; NONHUMAN; PREOPTIC AREA; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; SIGNAL TRANSDUCTION; TISSUE LEVEL; WEIGHT GAIN;

ANIMALS; COLCHICINE; EATING; GALANIN; HYPERPHAGIA; HYPOTHALAMUS; INSULIN; LEPTIN; MALE; MICROINJECTIONS; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; UP-REGULATION; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; WEIGHT GAIN;

EID: 0034016003     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00172-8     Document Type: Article

References (38)

1. Avrith D., Mogenson G.J. Reversible hyperphagia and obesity following intracerebral microinjections of colchicine into the ventromedial hypothalamus of the rat. Brain Res. 153:1978;99-107.
2. Bai F.L. An arcuato-paraventricular and dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 331:1985;172-175.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
4. Bray G.A. Syndromes of hypothalamic obesity in man. Pediatr Ann. 13:1984;525-536.
5. Choi S., Dallman M.F. Hypothalamic obesity multiple routes mediated by loss of function in medial cell groups . Endocrinology. 140:1999;4081-4088.
6. Choi S., Horsley C., Aguila S., Dallman M.F. The hypothalamic ventromedial nuclei couple activity in the hypothalamo-pituitary-adrenal axis to the morning fed or fasted state. J Neurosci. 16:1996;8170-8180.
7. Dube M.G., Horvath T.L., Leranth C., Kalra P.S., Kalra S.P. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav. 56:1994;811-813.
8. Dube M.G., Xu B., Kalra P.S., Sninsky C.A., Kalra S.P. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res. 816:1999;38-46.
9. Fehmann H.-C., Peiser C., Bode H.-P., Stamm M., Staats P., Hedetoft C., Lang R.E., Göke B. Leptin a potent inhibitor of insulin secretion . Peptides. 18:1997;1267-1273.
10. Hetherington A.W., Ranson S.W. Hypothalamic lesions and adiposity in the rat. Anatom Rec. 78:1940;149-172.
11. Jain M.R., Dube M.G., Kalra S.P., Kalra P.S. Neuropeptide Y release in the paraventricular nucleus is decreased during transient hyperphagia induced by microinjection of colchicine into the ventromedial nucleus of rats. Neurosci Lett. 256:1998;21-24.
12. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev. 20:1999;68-100.
13. Kalra S.P., Dube M.G., Sahu A., Phelps C.P., Kalra P.S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA. 88:1991;10931-10935.
14. Kalra P.S., Dube M.G., Xu B., Farmerie W.G., Kalra S.P. Neuropeptide Y (NPY) Y1 receptor mRNA is up-regulated in association with transient hyperphagia and body weight gain evidence for a hypothalamic site for concurrent development of leptin resistance . J Neuroendocrinol. 10:1998;43-49.
15. Kalra P.S., Dube M.G., Xu B., Kalra S.P. Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain. Regul Pept. 72:1997;121-130.
16. Koyama K., Chen G., Wang M.-Y., Lee Y., Shimabukuro M., Newgard C.B., Unger R.H. β-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes. 46:1997;1276-1280.
17. Kulkarni R.N., Wang Z.-L., Wang R.-M., Hurley J.D., Smith D.M., Ghatei M.A., Withers D.J., Gardiner J.V., Bailey C.J., Bloom S.R. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest. 100:1997;2729-2736.
18. Kyrkouli S.E., Stanley B.G., Leibowitz S.F. Galanin stimulation of feeding induced by medial hypothalamic injection of this novel peptide . Eur J Pharmacol. 122:1986;159-160.
19. Kyrkouli S.E., Stanley B.G., Seirafi R.D., Leibowitz S.F. Stimulation of feeding by galanin anatomical localization and behavioral specificity of this peptide's effects in the brain . Peptides. 11:1990;995-1001.
20. Leibowitz S.F., Akabayashi A., Wang J. Obesity on a high-fat diet role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence . J Neurosci. 18:1998;2709-2719.
21. Melander T., Hökfelt T., Rökaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol. 248:1986;475-517.
22. Merchenthaler I., Lopez F.J., Negro-Vilar A. Anatomy and physiology of central galanin-containing pathways. Prog Neurobiol. 40:1993;711-769.
23. Mundy W.R., Tilson H.A. Neurotoxic effects of colchicine. Neurotoxicology. 11:1990;539-548.
24. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, San Diego.
25. Perisic M., Cuenod M. Synaptic transmission depressed by colchicine blockade of axoplasmic flow. Science. 1975:1972;1140-1142.
26. Pu S., Dube M.G., Edwards T.G., Kalra S.P., Kalra P.S. Disruption of neural signaling within the hypothalamic ventromedial nucleus up-regulates galanin gene expression in association with hyperphagia an in situ hybridization analysis . Brain Res Mol Brain Res. 64:1999;85-91.
27. Pu S, Dube MG, Xu B, Kalra SP, Kalra PS. Induction of neuropeptide Y (NPY) gene expression in novel hypothalamic sites in association with transient hyperphagia and bodyweight gain. 80th Ann Mtg Endo Soc June 24-27, 1998, Abst. P3-217, P-432.
28. Sahu A. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology. 139:1998;795-798.
29. Sahu A. Leptin decreases food intake induced by melanin-concentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat. Endocrinology. 139:1998;4739-4742.
30. Sahu A., Sninsky C.A., Kalra P.S., Kalra S.P. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology. 126:1990;192-198.
31. Saladin R., De Vos P., Guerre-Millo M., Leturque A., Girard J., Staels B., Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:1995;527-529.
32. Satoh N., Ogawa Y., Katsuura G., et al. Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats evidence for loss of its satiety effect in VMH-lesioned rats . Endocrinology. 138:1997;947-954.
33. Schick R.R., Samsami S., Zimmermann J.P., Eberl T., Endres C., Schusdziarra V., Classen M. Effect of galanin on food intake in rats involvement of lateral and ventromedial hypothalamic sites . Am J Physiol. 264:1993;R355-R361.
34. Spiegelman B.M., Flier J.S. Adipogenesis and obesity rounding out the big picture . Cell. 87:1996;377-389.
35. Tang C., Akabayashi A., Manitiu A., Leibowitz S.F. Hypothalamic galanin gene expression and peptide levels in relation to circulating insulin possible role in energy balance . Neuroendocrinology. 65:1997;265-275.
36. Tempel D.L., Leibowitz S.F. Galanin inhibits insulin and corticosterone release after injection into the PVN. Brain Res. 536:1990;353-357.
37. Wang J., Leibowitz K.L. Central insulin inhibits hypothalamic galanin and neuropeptide Y gene expression and peptide release in intact rats. Brain Res. 777:1997;231-236.
38. Zheng D., Jones J.P., Usala S.J., Dohm G.L. Differential expression of ob mRNA in rat adipose tissues in response to insulin. Biochem Biophys Res Commun. 218:1996;434-437.